The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Single-Cell Analysis Transcriptomics Market During 2026–2030?
The market size for single-cell analysis transcriptomics has seen rapid growth over recent years. It is projected to increase from $1.08 billion in 2025 to $1.22 billion by 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical expansion can be attributed to the significant cost of early sequencing equipment, limited access to microfluidics technologies, a previous reliance on conventional bulk tissue analysis, increasing academic research funding, and a developing awareness of cellular heterogeneity.
The single-cell analysis transcriptomics market is anticipated to experience substantial growth in the upcoming years. Its value is projected to reach $1.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This expansion during the forecast period is driven by factors such as advancements in single-cell sequencing platforms, the integration of cloud-based bioinformatics solutions, increasing investment from pharmaceutical and biotechnology companies, greater adoption in personalized medicine, and the broader application in hospital and diagnostic centers. Prominent trends for the forecast period include the increasing uptake of single-cell RNA sequencing techniques, a rising utilization of microfluidics-based platforms, the expansion of clinical diagnostics applications, growth in drug discovery and development research, and enhanced data analysis and bioinformatics capabilities.
Access Your Free Sample Report For In-Depth Market Analysis:
What Factors Are Contributing To The Growth Of The Single-Cell Analysis Transcriptomics Market?
The future expansion of the single-cell analysis transcriptomics market is anticipated to be significantly driven by the growing integration of personalized medicine. This medical approach involves tailoring treatments to an individual’s specific genetic makeup, lifestyle, and environmental factors. The rising acceptance of personalized medicine stems from advancements in genetic sequencing, which facilitate the creation of highly effective, individualized treatments. Single-cell analysis transcriptomics plays a crucial role by revealing unique gene expression profiles, thereby informing personalized therapeutic strategies that align with a patient’s distinct biology. This not only improves treatment efficacy and reduces adverse effects but also aids in the early detection of diseases. For example, in February 2024, the U.S. Food and Drug Administration, as per the Personalized Medicine Coalition, sanctioned 16 new personalized treatments for rare disease patients in 2023, a notable increase from 6 in 2022. Consequently, the increasing adoption of personalized medicine is a key factor propelling the growth of the single-cell analysis transcriptomics market.
Which Segment Categories Are Included In The Single-Cell Analysis Transcriptomics Market Segment Analysis?
The single-cell analysis transcriptomics market covered in this report is segmented –
1) By Component: Equipment, Consumables, Software And Services
2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies
3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training
What Trends Are Shaping The Future Of The Single-Cell Analysis Transcriptomics Market?
Leading companies operating in the single cell analysis transcriptomics market are prioritizing the development of innovative offerings, such as single cell RNA sequencing kits, to streamline processes and gain deeper insights into cellular variations. A single cell RNA sequencing kit functions as a specialized tool for isolating and analyzing gene expression at the individual cell level. It empowers researchers to uncover cellular diversity and acquire understanding into complex biological mechanisms. For instance, in January 2024, Scale Biosciences, a US-based biotechnology company specializing in single cell solutions, introduced the Single Cell RNA Kit v1.1-Extended Throughput, enabling the processing of up to 500,000 cells per run through an instrument-free workflow. This launch considerably enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.
Who Are The Active Companies Shaping The Single-Cell Analysis Transcriptomics Market?
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences
Get The Full Single-Cell Analysis Transcriptomics Market Report:
Which Region Dominates The Single-Cell Analysis Transcriptomics Market By Market Share?
North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Single-Cell Analysis Transcriptomics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Single-Cell Analysis Transcriptomics Market 2026, By The Business Research Company
Single Cell Analysis Market 2026
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market
Single Cell Omics Market Report 2026
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report
Rna Analysis Transcriptomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model